Introduction

An enduring significance attaches to the legal issues at the heart of the current dispute on biotech products in the World Trade Organization (WTO) between the United States, Canada and Argentina on the one hand, and the European Communities (EC) on the other, known as the EC - Approval and Marketing of Biotech Products case (the Biotech case).1 While provisions relevant to protection of human health and the environment constitute just one feature of the large body of WTO law that now exists, they govern an aspect of international trade that is of considerable social, political and ...